Aphexda 62 mg/1.7mL
Motixafortide · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BioLineRx USA Inc
Motixafortide (Aphexda) is a prescription injection given under the skin that is used to help mobilize blood-forming stem cells from the bone marrow in patients preparing for stem cell transplantation. It works by temporarily increasing the number of these cells available in the bloodstream for collection.
Key Facts
- Brand Name
- Aphexda
- Generic Name
- Motixafortide
- NDC Code (Product)
82737-073- Manufacturer
- BioLineRx USA Inc
- Strength
- 62 mg/1.7mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA217159
- Marketing Start
- 09/08/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Aphexda used for?
Motixafortide (Aphexda) is a prescription injection given under the skin that is used to help mobilize blood-forming stem cells from the bone marrow in patients preparing for stem cell transplantation. It works by temporarily increasing the number of these cells available in the bloodstream for collection.
Is Aphexda a controlled substance?
Aphexda is not classified as a controlled substance by the DEA.
What is the generic name for Aphexda?
The generic name for Aphexda is Motixafortide. There are 1 other brand versions of Motixafortide.
What is the NDC code for Aphexda 62 mg/1.7mL?
The NDC (National Drug Code) for Aphexda 62 mg/1.7mL is 82737-073, listed by BioLineRx USA Inc.